UNSPSC 51351529: Progesterone caproate

This classification denotes a progestagen with the molecular formula C27H40O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 276F2O42F5, chemically known as pregn-4-ene-3,20-dione, 17-((1-oxohexyl)oxy)-, but more generally known as progesterone caproate, which bears US NIH Compound Identifier 12419. European Medicines Agency schedules progesterone caproate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10076MIG.

Most nations, for tariff purposes, schedule progesterone caproate under HS 29372300. SMILES: CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C.

UNSPSC 51351529 Progesterone caproate is a Commodity code representing a pharmaceutical hormone product that state and local health authorities and procurement offices acquire for clinical and public health programs. The code covers progesterone caproate, a progestin used in reproductive health, contraception, and hormone therapy applications where public health systems, corrections departments, and safety-net clinics maintain formulary stock or support patient treatment protocols.

The source provided contains no recent state and local contract opportunities under this code and does not identify the mix of issuing bodies, geographic regions, or representative solicitations currently active in the market for progesterone caproate procurement.